$康方生物(09926)$ 康方112EGFR耐药重磅来袭
Ivonescimab combined with chemotherapy in patients with EGFR-mutant nonsquamous non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor treatment (HARMONi-A): A randomized, double-blind, multi-center, phase 3 t...